EcoDrugPlus

Ensembl ID : YHR200W
Description: -
73 Possible Orthologues:

Title

Ensembl ID : YHR202W
Description: -
222 Possible Orthologues:

Title

Ensembl ID : YHR203C
Description: -
125 Possible Orthologues:

Title

Ensembl ID : YIL018W
Description: -
195 Possible Orthologues:

Title

Ensembl ID : YIL033C
Description: -
75 Possible Orthologues:

Title

Ensembl ID : YIL035C
Description: -
130 Possible Orthologues:

Title

Ensembl ID : YIL069C
Description: -
91 Possible Orthologues:

Title

Ensembl ID : YIL075C
Description: -
85 Possible Orthologues:

Title

Ensembl ID : YIL133C
Description: -
122 Possible Orthologues:

Title

Ensembl ID : YIL172C
Description: -
322 Possible Orthologues:

Title

Ensembl ID : YIR035C
Description: -
1039 Possible Orthologues:

Title

Ensembl ID : YIR036C
Description: -
1039 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).